Trader J's Inner Circle Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Trader J's Inner Circle

NVDA 183.82

+2.3%

12:47 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: bluejeans who wrote (23150)	11/22/1999 7:55:00 PM
From: Softechie	Read Replies (1) of 56535

bluejeans I sent them PM's and they haven't replied to me in 4-5 weeks now. Forget those guys. Avanir is very speculative play but the risks are diminishing at this point. Looking back I was a "crazy man" buying like mad from 5/16 to 3/8 but hey "Judgement Call" from FDA is just not concrete decision at all. Well anyway we are going to make money on this company. Remember cold sores market is $1B and herpes and burns markets will add substantially. This is what I think. Marketing partner will get about 60% of gross revenue and Avanir will get about 40% which is very good. I'm looking for $3 end of year and possibly much higher next year when revenue starting to flow in.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next